Patent ID: 8715681

Claim:
A method for inducing an immune response comprising administering in a subject a composition comprising one or more B-cell epitopes present in HPV 58/L1 protein, wherein one B-cell epitope is a peptide from 4 to 7 amino acid residues in length and comprises a sequence selected from the group consisting of: YLPPVP (SEQ ID NO: 1) corresponding to amino acids 38-43 of HPV58 L1/1; PNKFGP (SEQ ID NO: 2) corresponding to amino acids 107-112 of HPV58/L1-2; GHPYLN (SEQ ID N.33) corresponding to amino acids 146-151 of HPV58/L1-2B; DDTE (SEQ ID NO: 3) corresponding to amino acids 154-157 of HPV58/L1-3; YPAQPGS (SEQ ID NO: 34) corresponding to amino acids 162-168 of HPV58/L1-3B; ATDC (SEQ ID NO: 4) corresponding to amino acids 208-211 of HPV58/LI-4; PLELF (SEQ ID NO: 5) corresponding to amino acids 213-217 of HPV58/L1-5; EDGDMV (SEQ ID NO: 6) corresponding to amino acids 222-227 of HPV58/L1-6; DTGF (SEQ ID NO: 7) corresponding to amino acids 228-231 of HPV58/L1-7; FGTLQAN (SEQ ID NO: 8) corresponding to amino acids 236-242 of HPV58/L1-8; DVPID (SEQ ID NO: 9) corresponding to amino acids 245-249 of HPV58/L1-9; PDDL (SEQ ID NO: 10) corresponding to amino acids 298-301 of HPV58/L1-10; QLFNK (SEQ ID NO: 11) corresponding to amino acids 331-335 of HPV58/L1-11; GTYK (SEQ ID NO: 12) corresponding to amino acids 378-381 of HPV58/L1-12; DNFKEY (SEQ ID NO: 13) corresponding to amino acids 383-388- of HPV58/L1-13; KEDP (SEQ ID NO: 14) corresponding to amino acids 462-465 of HPV58/L1-14; or KAKPRLK (SEQ ID NO: 15) corresponding to amino acids 500-506 of HPV58/L1-15.